Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study
MONMOUTH JUNCTION, N.J., Dec. 9, 2020 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world,…
Comments Off on Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study